Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2004, Vol. 103, No. 4, pp. 1244-1252.
Prepublished online as a Blood First Edition Paper on October 23, 2003; DOI 10.1182/blood-2003-06-2171.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-06-2171v1
103/4/1244    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katano, H.
Right arrow Articles by Cohen, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katano, H.
Right arrow Articles by Cohen, J. I.
Related Collections
Right arrow Immunobiology
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS

Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation

Harutaka Katano, Mir A. Ali, Andriani C. Patera, Marta Catalfamo, Elaine S. Jaffe, Hiroshi Kimura, Janet K. Dale, Stephen E. Straus, and Jeffrey I. Cohen

From the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); the Experimental Immunology Branch and the Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD; and the Department of Pediatrics, Nagoya University Graduate School of Medicine, Aichi, Japan.

Chronic active Epstein-Barr virus infection (CAEBV) is a rare disease in which previously healthy persons develop severe, life-threatening illness. Mutations in the perforin gene have been found in familial hemophagocytic lymphohistiocytosis, which shares some features with CAEBV. We studied a patient who died at age 18, 10 years after the onset of CAEBV. The patient had high titers of antibodies to EBV, EBV RNA in lymph nodes, T-cell lymphoproliferative disease, and hemophagocytic lymphohistiocytosis. DNA sequencing showed novel mutations in both alleles of the perforin gene that resulted in amino acid changes in the protein. The quantity of the native form of perforin from the patient's stimulated peripheral blood mononuclear cells (PBMCs) was extremely low and immunoblotting showed accumulation of an uncleaved precursor form of perforin. Stimulated PBMCs from the patient were defective for Fas-independent cytotoxicity. These data imply that mutations in this patient resulted in reduced perforin-mediated cytotoxicity by his lymphocytes. This is the first case in which perforin mutations have been shown to result in accumulation of the uncleaved, immature form of perforin. Mutations in the perforin gene are associated with some cases of CAEBV with hemophagocytic lymphohistiocytosis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H. Williams and D. H. Crawford
Epstein-Barr virus: the impact of scientific advances on clinical practice
Blood, February 1, 2006; 107(3): 862 - 869.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Trambas, F. Gallo, D. Pende, S. Marcenaro, L. Moretta, C. De Fusco, A. Santoro, L. Notarangelo, M. Arico, and G. M. Griffiths
A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin
Blood, August 1, 2005; 106(3): 932 - 937.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Loh, D. A. Thomas, P. A. Revell, T. J. Ley, and H. W. Virgin IV
Granzymes and Caspase 3 Play Important Roles in Control of Gammaherpesvirus Latency
J. Virol., November 15, 2004; 78(22): 12519 - 12528.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. J. Karandikar, S. H. Kroft, S. Yegappan, B. B. Rogers, V. M. Aquino, K.-M. Lee, V. Kumar, F. J. Guenaga, E. S. Jaffe, D. C. Douek, et al.
Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis
Blood, October 1, 2004; 104(7): 2007 - 2009.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020